Beijing Anzhen Hospital
Beijing, Beijing Municipality, 100029, China
Location contact
Xiujing Shi, MD
CONTACT
Yang Lin, PhD
CONTACT
NCT Number: NCT04184583
Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100029, China
Xiujing Shi, MD
CONTACT
Yang Lin, PhD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 5 years
MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization.
Time frame: up to 5 years
Adverse drug reaction will be defined as any adverse reactions in the patients.
Contact information is provided by the study sponsor or research team.
Yang Lin, PhD
CONTACT
Yi Zhang, PhD
CONTACT
Beijing Anzhen Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07665697
Drug Therapy, Immune Checkpoint Inhibitors (ICIs)
Chengdu, China
View Trial DetailsNCT06539559
Bevacizumab, Breast Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06223568
Cancer Vaccine, Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT04478838
Antipsychotic Agents, Drug Administration Schedule
Toronto, Ontario, Canada
View Trial Details